Centene delivered better-than-expected results in Q3 2026, buoyed by strength in its Medicare and Marketplace businesses. Management highlighted that favorable medical cost trends in Medicare Advantage and disciplined cost management in Medicaid helped offset utilization pressures in specific geographies, such as Florida. CEO Sarah London emphasized continued stabilization in behavioral health and home health trends, as well as effective fraud and abuse controls, as key drivers of the quarter. The company also noted strong execution in its turnaround plan for both Medicare and the Marketplace, with the latter absorbing adjustments from integrity measures without derailing profitability.
Is now the time to buy CNC? Find out in our full research report (it’s free for active Edge members).
Centene (CNC) Q3 2026 highlights:
- Revenue $50.65 billion vs S&P analysts’ estimates of $46.81 billion (1.9% year-on-year growth, 8.2% beat)
- Adjusted EPS $0.58 vs S&P analysts’ estimates of $0.10 (significant beat)
- Revenue guidance The company lifted its revenue guidance for the full year to $198.5 billion at the midpoint from $195.5 billion, a 1.5% increase
- Adjusted EPS guidance Management raised its full-year adjusted EPS guidance to $5.20 at the midpoint, a 8.3% increase
- Operating margin -0.6%, up from -14% in the same quarter last year
- Customers 25.7 million, down from 25.89 million in the previous quarter
- Market capitalization $33.19 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our top 5 analyst questions from Centene’s Q3 earnings call
- David Windley (Jefferies) sought details on Medicaid rate adjustments and state engagement. CEO Sarah London described positive signals, noting explicit rate provisions for acuity shifts and improved data exchange with states, which support prospective rate alignment.
- Justin Lake (Wolfe Research) questioned Marketplace growth prospects and PDP margin resets. London said Marketplace growth may contract slightly but is positioned for margin expansion, while CFO Drew Asher expects PDP margins to reset to the 2%-3% range as IRA impacts fade.
- Steven Baxter (Wells Fargo) asked about the impact of IDR catch-up and full-year margin guidance. Asher explained that Marketplace fundamentals absorbed reserve increases, enabling the segment to reach the top end of margin guidance without expecting similar headwinds in Q4.
- AJ Rice (UBS) queried on G&A improvement sustainability and exchange seasonality. London confirmed that G&A reductions stem from ongoing structural changes, with normal Q4 seasonality expected for commission-based businesses.
- Ann Hynes (Mizuho Securities) requested insight into Marketplace pricing and metal mix strategy for 2027. London outlined a county-level approach, emphasizing affordability and margin balance, with continued focus on the bronze tier but no major mix shifts anticipated.
Catalysts in upcoming quarters
In the coming quarters, the StockStory team will monitor (1) Medicaid membership trends as states implement work requirements and conduct eligibility reviews, (2) the pace and sustainability of margin gains in both Medicare and Marketplace segments as product and pricing strategies evolve, and (3) ongoing SG&A optimization through automation and operational streamlining. The ability to maintain positive state relationships and adapt to regulatory changes will also be key signs of execution.
Centene currently trades at $67.75, in line with $68.03 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
Our favorite stocks right now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
